Seattle Biotech Layoffs Since 2002

2002 - Amgen buys Immunex, lays off ~500
2003 -
Celltech shuts down Bothell group, lays off 90
2004 -
Ceptyr cuts half its staff (~20 jobs)
2005 -
NeoRx cuts staff 40% (20 jobs)
2005 -
Corixa lays off 65% staff (70 jobs)
2005 -
CTI cuts 75 jobs; ends research in Seattle
2005 -
Xcyte shuts down; loss of ~100 jobs
2006 -
Dendreon cuts 34 jobs
2006 -
Eden Bioscience cuts “substantial” jobs
2006 -
Glaxo closes Bothell vaccine research, ends 70 jobs
2006 -
Glaxo closes down Corixa, cuts remaining jobs
2006 -
Eli Lilly buys Icos, cuts ~700 jobs
2006 -
Targeted Genetics cuts 27% of jobs (26 jobs)
2007 -
Amgen cuts 12-14% staff, ~130 jobs
2007 -
Nastech lays off 72
2008 -
CTI cuts 31 jobs
2008 -
Nastech lays off another 50 people
2008 -
Zymogenetics lays off 80 people
2008 -
Northstar Neuroscience lays off ~25 people
2008 -
Rosetta Inpharmatics lays off 12 people
2008 -
Nastech lays off another 20 people
2008 -
Plexera Bioscience shuts down, lays off 23
2008 -
MDRNA (formerly Nastech) lays off another 23 people
2008 -
Northstar Neuroscience lays off another 20 people
2008 -
Cellcyte Genetics lays off staff (number not specified)
2008 -
Acucela lays off 9 staff members (slightly less than 1/3)
2008 -
Targeted Genetics lays off 7, cuts hours, salaries of others
2008 -
Oncothyreon lays off 8
2008 -
Cellcyte Genetics runs out of cash, goes under, layoff numbers not put forth
2009 -
Eden Biosciences to liquidate
2009 -
VizX to be liquidated after selling technology to Geospiza
2009 -
Northstar Neurosciences shutting down, lay off 38
2009 -
Rosetta Inpharmatics (Merck) site to shut down, laying off 240
2009 -
CMC Icos cuts 11 jobs one month after postponing expansion plans
2009 -
Trubion lays off 25, citing the declining economy
2009 -
CTI cuts 62 jobs in their Italian branch
2009 -
CTI cuts 34 jobs in their Seattle branch, or 28% of the workforce
2009 -
Poniard cuts 8 jobs (location?); or 12% of the workforce
2009 -
Amgen cuts 100 workers in Bothell
2009 -
Zymogenetics lays off 161 people (32% of workforce)
2009 -
Targeted Genetics lays off about 20 people (1/2 of workforce)
2009 -
Zymogenetics lays off 52 people (15% of workforce), ends research 
2009 -
VLST lays off 12 people
2010 -
Poniard lays off 57% of staff (28 people) leaving 21
2011 -
Dendreon lays off 500 workers (25% of staff)
2011 -
Amgen lays off 69 workers in Seattle/Bothell; 380 overall
2011 -
AVI Biopharma axes 28% of workforce (35 jobs)
2012 -
Marina Biotech lays off 45; halts most operations
2012 -
Dendreon lays off 600; restructures
2012 -
Sarepta (formerly AVI Biopharma) moves to Boston and takes 40 jobs out of state
2012 -
VLST lays off 12 of 17 workers; shifts focus to clinic
2012 -
AMRI closes contract research site in Bothell, moves job function to Singapore; 24 jobs lost
2013 -
Acucela lays off 30
2013 -
VLST shuts down operations with an unknown number of layoffs
2014 - Amgen closes down operations in WA State, eliminating 660 jobs
2014 -
Novo Nordisk cuts 63 jobs in Seattle
2014 -
Allozyne folds and its IP is sold off; layoff numbers not announced
2015 -
Dendreon (now owned by Valeant) lays off 77 as it restructures
2016 -
Oncogenex lays off 11 people

Stacks Image 5521